Core needle biopsy (CNB) is an important tool to ensure a diagnosis of breast cancer and assess biomarkers including estrogen receptor (ER), progesterone receptor (PR), proliferation markers such as Ki67, and human epidermal growth factor receptor 2 (HER2) status before the initiation of breast cancer treatment1. Here, ESR1 is linked to breast cancer.